Skip to content

Stereotaxis STXS Net margin

Net margin at other companies

Abbott logo
AbbottABT
13.9%-18.0pp
Boston Scientific logo
Boston ScientificBSX
17.3%+5.7pp
Medtronic logo
MedtronicMDT
13.2%-0.7pp
Stryker logo
StrykerSYK
13.2%+0.9pp
ITG
Integer HoldingsITGR
7.6%+3.2pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9%+0.2pp

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Calculated from Stereotaxis’s reported figures.

Based on trailing twelve months.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's net margin?
Stereotaxis (STXS) reported net margin of -69.5% in Q1 2026.
How has Stereotaxis's net margin changed year-over-year?
Stereotaxis's net margin increased by 24.6% year-over-year, from -92.2% to -69.5%.
What is the long-term trend for Stereotaxis's net margin?
Over 5 years (2020 to 2025), Stereotaxis's net margin has grown at a 21.8% compound annual growth rate (CAGR), from -25% to -66.8%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.